FI863956A - Foerfarande foer framstaellning av sulfonyl-fenylalkylaminer. - Google Patents

Foerfarande foer framstaellning av sulfonyl-fenylalkylaminer. Download PDF

Info

Publication number
FI863956A
FI863956A FI863956A FI863956A FI863956A FI 863956 A FI863956 A FI 863956A FI 863956 A FI863956 A FI 863956A FI 863956 A FI863956 A FI 863956A FI 863956 A FI863956 A FI 863956A
Authority
FI
Finland
Prior art keywords
alkyl
group
atoms
radical
aralkyl
Prior art date
Application number
FI863956A
Other languages
English (en)
Other versions
FI863956A0 (fi
Inventor
Ernst-Christian Witte
Hans-Peter Wolff
Karlheinz Stegmeier
Johannes Pill
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI863956A0 publication Critical patent/FI863956A0/fi
Publication of FI863956A publication Critical patent/FI863956A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
FI863956A 1985-10-02 1986-09-30 Foerfarande foer framstaellning av sulfonyl-fenylalkylaminer. FI863956A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853535167 DE3535167A1 (de) 1985-10-02 1985-10-02 Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel

Publications (2)

Publication Number Publication Date
FI863956A0 FI863956A0 (fi) 1986-09-30
FI863956A true FI863956A (fi) 1987-04-03

Family

ID=6282575

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863956A FI863956A (fi) 1985-10-02 1986-09-30 Foerfarande foer framstaellning av sulfonyl-fenylalkylaminer.

Country Status (16)

Country Link
US (1) US4948809A (fi)
EP (1) EP0221344B1 (fi)
JP (1) JPH0710827B2 (fi)
KR (1) KR870003977A (fi)
AT (1) ATE53015T1 (fi)
AU (1) AU597000B2 (fi)
DD (1) DD252187A5 (fi)
DE (2) DE3535167A1 (fi)
DK (1) DK468786A (fi)
ES (1) ES2036168T3 (fi)
FI (1) FI863956A (fi)
HU (1) HU201735B (fi)
IL (1) IL80172A0 (fi)
PL (1) PL147258B1 (fi)
PT (1) PT83479B (fi)
ZA (1) ZA867442B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GB8528398D0 (en) * 1985-11-19 1985-12-24 Glaxo Group Ltd Chemical compounds
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
DE3819052A1 (de) * 1988-06-04 1989-12-07 Basf Ag Neue sulfonamid-derivate, ihre herstellung und verwendung
DE3829455A1 (de) * 1988-08-31 1990-03-15 Boehringer Mannheim Gmbh Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US5041232A (en) * 1990-03-16 1991-08-20 Lever Brothers Company, Division Of Conopco, Inc. Sulfonimines as bleach catalysts
US5189211A (en) * 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
DE4109735A1 (de) * 1991-03-25 1992-10-01 Boehringer Mannheim Gmbh Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
WO1996036595A1 (en) * 1995-05-19 1996-11-21 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
US6653331B2 (en) * 1996-07-03 2003-11-25 Pharmacia & Upjohn Company Targeted drug delivery using sulfonamide derivatives
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
US6693137B1 (en) 1998-07-31 2004-02-17 Eli Lilly And Company Sulphonamide derivatives
AU3329400A (en) * 1999-03-31 2000-10-23 Kissei Pharmaceutical Co. Ltd. 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
MXPA02004985A (es) * 1999-11-26 2003-10-14 Shionogi & Co Antagonistas del neuropeptido y, y5.
AU2002234165A1 (en) 2000-11-03 2002-05-27 Tularik, Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
FR2817256B1 (fr) * 2000-11-27 2005-07-15 Univ Pasteur Derives de l'acides 4-hydroxybutanoique et de son homologue superieur comme ligands des recepteurs du gamma- hydroxybutyrate (ghb), compositions pharmaceutiques les contenant et utilisations pharmaceutiques
SE0402635D0 (sv) * 2004-10-29 2004-10-29 Astrazeneca Ab Chemical compounds
US20090093485A1 (en) * 2004-10-29 2009-04-09 Astrazeneca Ab Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
FI20055498A0 (fi) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamidijohdannaisia
TW200815361A (en) * 2005-10-20 2008-04-01 Astrazeneca Ab Chemical compounds
US7750103B2 (en) * 2006-09-08 2010-07-06 The University Of Massachusetts Cyclooctene monomers and polymers, and water purification articles and methods utilizing them
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
JO2754B1 (en) * 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
GB0705400D0 (en) * 2007-03-21 2007-05-02 Univ Aberdeen Therapeutic compounds andm their use
JP5496913B2 (ja) * 2008-01-15 2014-05-21 ウェルスタット セラピューティクス コーポレイション 代謝異常の治療のための化合物
US20100080786A1 (en) * 2008-05-20 2010-04-01 Markus Berger Phenyl or Pyridinyl Substituted Indazoles Derivatives
GB0817207D0 (en) 2008-09-19 2008-10-29 Pimco 2664 Ltd therapeutic apsac compounds and their use
GB0817208D0 (en) * 2008-09-19 2008-10-29 Pimco 2664 Ltd Therapeutic apsap compounds and their use
ES2352398B1 (es) * 2009-06-25 2011-09-29 Institut Univ. De Ciencia I Tecnologia S.A. N-fenetilsulfonamidas-n-sustituidas para la identificacion de actividad biologica y farmacologica.
GB201311361D0 (en) 2013-06-26 2013-08-14 Pimco 2664 Ltd Compounds and their therapeutic use
LT3262028T (lt) 2014-12-17 2022-01-10 Pimco 2664 Limited N-(4-hidroksi-4-metil-cikloheksil)-4-fenil-benzensulfonamido ir n-(-4-hidroksi-4-metil-cikloheksil)-4-(2-piridil)-benzensulfonamido junginiai ir jų terapinis panaudojimas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4219668A (en) * 1979-07-05 1980-08-26 American Cyanamid Company 4-Hydroxy,4-biphenylbutyric acid
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ES2036168T3 (es) 1993-05-16
DK468786A (da) 1987-04-03
PT83479B (de) 1988-11-02
DD252187A5 (de) 1987-12-09
US4948809A (en) 1990-08-14
EP0221344A1 (de) 1987-05-13
AU6346386A (en) 1987-04-16
AU597000B2 (en) 1990-05-24
HU201735B (en) 1990-12-28
KR870003977A (ko) 1987-05-06
FI863956A0 (fi) 1986-09-30
DK468786D0 (da) 1986-10-01
DE3671440D1 (de) 1990-06-28
PL261644A1 (en) 1988-03-03
ZA867442B (en) 1987-06-24
ATE53015T1 (de) 1990-06-15
PL147258B1 (en) 1989-05-31
JPS6284054A (ja) 1987-04-17
IL80172A0 (en) 1986-12-31
HUT43811A (en) 1987-12-28
DE3535167A1 (de) 1987-04-09
PT83479A (de) 1986-11-01
EP0221344B1 (de) 1990-05-23
JPH0710827B2 (ja) 1995-02-08

Similar Documents

Publication Publication Date Title
FI863956A0 (fi) Foerfarande foer framstaellning av sulfonyl-fenylalkylaminer.
ES414279A1 (es) Procedimiento para la preparacion de 1,4-benzodiazepinas.
SE7607566L (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
MY131501A (en) Process for the prepration of clavulanic acid
GR74703B (fi)
GR71716B (fi)
FI892914A (fi) Asyloitujen -aminohappoesterijohdannaisten käyttö hyönteisten ja punkkien torjuntaan
ES8604604A1 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
ATE155685T1 (de) Derivate des 6-amino-octahydro-indolizintriols
HUT45058A (en) Process for producing 6-hydroxy-methyl-carbapenem derivatives and pharmaceuticals comprising the same as active ingredient
ES418514A1 (es) Un metodo para preparar compuestos triciclicos sustituidos con tetrazolilo.
DK640489D0 (da) C63-amidderivater af 34-de-(acetylglucosaminyl)-34-deoxy-teicoplaniner
ES523890A0 (es) Un procedimiento para preparar derivados de penem.
ES8704918A1 (es) Un procedimiento para la preparacion de nuevos derivados de esteres fosforicos.
KR830010090A (ko) 아닐린 유도체의 제조방법
ATE149170T1 (de) Halogenalkyl-azolyl-derivate
ATE17352T1 (de) Cephalosporinverbindungen, ihre herstellung und sie enthaltende medikamente.
KR850000439A (ko) 티아졸리딘 유도체의 제조방법
ES8306099A1 (es) Un procedimiento para la preparacion de derivados de acido 2-(2-cianoetil)-2-benzoilamino-alcanoicos.
ES523659A0 (es) Procedimiento para la preparacion de compuestos de pirazina-bis (oxoglicina)antialergicos,especialmente n-n'-2 pirazina-diil) bis (2-oxoglicina), dietil ester.
FR2609464B1 (fr) Nouveaux derives du n-(1h-indol 4-yl) benzamide ainsi que leurs sels, leur application a titre de medicaments, et les compositions les renfermant
JPS6438062A (en) Novel alkylenediamine derivative and glutamic acid blocking agent
GR35674B (el) Μεθοδος δια την παρασκευην νεων αμιδιων αλειφατικων καρβονικων οξεων.
GR27998B (el) Μεθοδος δια την παρασκευην εστερων της ινδολικης σειρας.
GB1274198A (en) Cyanocyclopropane derivatives and their use as fungicides

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BOEHRINGER MANNHEIM GMBH